“We are going to probably go for a $1 billion capital raise at the end of this year via a QIP or take a financial investor into the company — all primary, no secondary,” Adar ...

Adar Poonawalla, head of the Serum Institute of India and now a major stakeholder in Dharma Productions with a 50% investment ...

Glass Lewis & Co. recommended that Keros stockholders vote “FOR” all three of the Company’s highly qualified director nominees, indicating support for the current Board's leadership. The ...

and in response to feedback gathered from stockholders – including ADAR 1 – on April 10, 2025, the Board determined to undertake a formal review process to evaluate strategic alternatives to maximize ...

AUSTIN - ADAR1 Capital Management, LLC, the major shareholder of Keros Therapeutics (NASDAQ:KROS), has urged the biotechnology firm to disclose the results of its strategic review before its upcoming ...

This conversion is called A-to-I mRNA editing. Proteins in the cell called ADAR are responsible for it. And when a ribosome reads from this mRNA to make the protein, it reads inosine as though it ...

Main Camera Triple 12 MP, f/1.7, 24mm (wide), 1/1.7", 1.8µm, dual pixel PDAF, OIS 12 MP, f/2.3, 85mm (telephoto), f/2.8, 125mm (telephoto), 1/3.5", dual pixel PDAF ...